Onychomycosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Merck, Novartis, Novartis, Pfizer, Bayer, Topica Pharma

DelveInsight's "Onychomycosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Onychomycosis, historical and forecasted epidemiology as well as the Onychomycosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Onychomycosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Onychomycosis Market Forecast
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Onychomycosis Market Report:
• The Onychomycosis market size was valued approximately USD 1,757 million in 2022 in the United States and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The total prevalence cases in the 7MM were determined. The estimated number of onychomycosis cases worldwide (7MMprevalent cases) in 2022 was close to 85,435,000, with the majority of cases being found in the US
• More than 13,390,000 cases of onychomycosis were diagnosed in total in the EU4 and UK markets in 2022, and this number is anticipated to climb during the projection period (2023-2022)
• The overall number of prevalent cases in Japan in 2022 exceeded 12,763,000
• According to analysts, there were roughly 4,000,000 mild cases, about 6,000,000 moderate cases, and about 5,000,000 severe cases of onychomycosis in the United States
• Key Onychomycosis Companies: Moberg Pharma, Blueberry Therapeutics, Hallux, Pfizer, MediQuest Therapeutics, Polichem S.A, Repolar Ltd., Celtic Pharma, GlaxoSmithKline, Hisamitsu Pharma, Polichem S.A., Pfizer, Bausch Health, Halcygen Pharma, Meiji Seika Pharma, photonamic GmbH, Viamet, Novartis, Topica Pharma, Taro Pharma, NanoBio Crp, Hallux, Inc., Merck Sharp & Dohme, Bayer, Abeona Therapeutics, Dow Pharma, Taro Pharma, and others
• Key Onychomycosis Therapies: MOB-015, BB2603, HSG, Tavaborole, MOB015B, P-3058, Organogel of naftifine, Amorolfine, TDT067 and Lamisil, Albaconazole, HTU-520, P-3058, AN2690, Efinaconazole, SUBA-itraconazole, ME1111, PD P 506 A, VT-1161, terbinafine, Luliconazole, NVXT topical, NB-002, HTS-519, SCH 56592, Bifonazole cream 1%, EcoNail™, IDP-108, Itraconazole, and others
• The Onychomycosis epidemiology based on gender analyzed that Onychomycosis is more common in females than males, in the United States
• The Onychomycosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Onychomycosis pipeline products will significantly revolutionize the Onychomycosis market dynamics.

Onychomycosis Overview
The most prevalent nail infection in the world, onychomycosis is a fungal infection that thickens and discolors the nail plate. However, recent studies have shown that mixed infections including those caused by nondermatophyte molds (NDMs) are more common than previously believed, especially in warmer areas. Dermatophytes were once assumed to be the primary cause of onychomycosis.

Get a Free sample for the Onychomycosis Market Report
https://www.delveinsight.com/report-store/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Onychomycosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Onychomycosis Epidemiology Segmentation:
The Onychomycosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Onychomycosis
• Prevalent Cases of Onychomycosis by severity
• Gender-specific Prevalence of Onychomycosis
• Diagnosed Cases of Episodic and Chronic Onychomycosis

Download the report to understand which factors are driving Onychomycosis epidemiology trends @ Onychomycosis Epidemiology Forecast
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Onychomycosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Onychomycosis market or expected to get launched during the study period. The analysis covers Onychomycosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Onychomycosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Onychomycosis Therapies and Key Companies
• MOB-015: Moberg Pharma
• BB2603: Blueberry Therapeutics
• HSG: Hallux
• Tavaborole: Pfizer
• MOB015B: Moberg Pharma AB
• P-3058: Polichem S.A.
• Organogel of naftifine: MediQuest Therapeutics
• Amorolfine: Repolar Ltd.
• TDT067 and Lamisil: Celtic Pharma
• Albaconazole: GlaxoSmithKline
• HTU-520: Hisamitsu Pharma
• P-3058: Polichem S.A.
• AN2690: Pfizer
• Efinaconazole: Bausch Health
• SUBA-itraconazole: Halcygen Pharma
• ME1111: Meiji Seika Pharma
• PD P 506 A: photonamic GmbH
• VT-1161: Viamet
• terbinafine: Novartis
• Luliconazole: Topica Pharma
• NVXT topical: Taro Pharma
• NB-002: NanoBio Crp
• HTS-519: Hallux, Inc.
• SCH 56592: Merck Sharp & Dohme
• Bifonazole cream 1%: Bayer
• EcoNail™: Abeona Therapeutics
• IDP-108: Dow Pharma
• Itraconazole: Taro Pharma

Discover more about therapies set to grab major Onychomycosis market share @ Onychomycosis Treatment Market
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Onychomycosis Market Strengths
• The introduction of novel, inexpensive, and non-invasive diagnostic technologies have led to rapid and accurate diagnosis of onychomycosis, hence increased the rate of diagnosis.

Onychomycosis Market Opportunities
• Current treatments have poor adherence and tolerability creating an opportunity for the key players to work on these areas

Scope of the Onychomycosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Onychomycosis Companies: Moberg Pharm, Blueberry Therapeutics, Hallux, Pfizer, MediQuest Therapeutics, Moberg Pharma AB, Polichem S.A, Repolar Ltd., Celtic Pharma, GlaxoSmithKline, Hisamitsu Pharma, Polichem S.A., Pfizer, Bausch Health, Halcygen Pharma, Meiji Seika Pharma, photonamic GmbH, Viamet, Novartis, Topica Pharma, Taro Pharma, NanoBio Crp, Hallux, Inc., Merck Sharp & Dohme, Bayer, Abeona Therapeutics, Dow Pharma, Taro Pharma, and others
• Key Onychomycosis Therapies: MOB-015, BB2603, HSG, Tavaborole, MOB015B, P-3058, Organogel of naftifine, Amorolfine, TDT067 and Lamisil, Albaconazole, HTU-520, P-3058, AN2690, Efinaconazole, SUBA-itraconazole, ME1111, PD P 506 A, VT-1161, terbinafine, Luliconazole, NVXT topical, NB-002, HTS-519, SCH 56592, Bifonazole cream 1%, EcoNail™, IDP-108, Itraconazole, and others
• Onychomycosis Therapeutic Assessment: Onychomycosis current marketed and Onychomycosis emerging therapies
• Onychomycosis Market Dynamics: Onychomycosis market drivers and Onychomycosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Onychomycosis Unmet Needs, KOL's views, Analyst's views, Onychomycosis Market Access and Reimbursement

To know more about Onychomycosis companies working in the treatment market, visit @ Onychomycosis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Onychomycosis Market Report Introduction
2. Executive Summary for Onychomycosis
3. SWOT analysis of Onychomycosis
4. Onychomycosis Patient Share (%) Overview at a Glance
5. Onychomycosis Market Overview at a Glance
6. Onychomycosis Disease Background and Overview
7. Onychomycosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Onychomycosis
9. Onychomycosis Current Treatment and Medical Practices
10. Onychomycosis Unmet Needs
11. Onychomycosis Emerging Therapies
12. Onychomycosis Market Outlook
13. Country-Wise Onychomycosis Market Analysis (2019-2032)
14. Onychomycosis Market Access and Reimbursement of Therapies
15. Onychomycosis Market Drivers
16. Onychomycosis Market Barriers
17. Onychomycosis Appendix
18. Onychomycosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Onychomycosis Pipeline
https://www.delveinsight.com/report-store/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Onychomycosis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Onychomycosis market. A detailed picture of the Onychomycosis pipeline landscape is provided, which includes the disease overview and Onychomycosis treatment guidelines.
Onychomycosis Epidemiology
https://www.delveinsight.com/report-store/onychomycosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Onychomycosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Onychomycosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Patient Monitoring Devices Market https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028.

Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028.

Resorbable Vascular Scaffolds Market https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
DelveInsight's 'Resorbable Vascular Scaffolds - Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Protein Supplements Market
https://www.delveinsight.com/report-store/protein-supplements-market
Protein Supplements Market By Source (Animal-Based [Whey, Casein, Fish, Eggs, Others], Plant-Based [Soy, Rice, Pea, Spirulina, Others]), By Product Type (Protein Powders, Protein Bars, Ready-To-Drink, And Others), By Application (Sports Nutrition And Functional Foods), By Distribution Channel (Supermarkets And Hypermarkets, E-Commerce, Direct-To-Consumer, Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing consumer awareness of having a protein rich diet,

Proteomics Market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028.

Infrared Thermometer Market
https://www.delveinsight.com/report-store/infrared-thermometer-market
Infrared Thermometer Market By Product Type (Contact Thermometers And Non-Contact Thermometers), By End-User (Food And Beverage Industry, Electronic Industry, Healthcare Industry, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing need for robust temperature measuring devices in critical industries and rise in the number of infectious diseases across the globe.

Hemoglobinopathies Market
https://www.delveinsight.com/report-store/sport-nutrition-market
Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe

Sport Nutrition Market
https://www.delveinsight.com/report-store/sport-nutrition-market
The Sports Nutrition Market By Product Type (Sports Drinks And Sports Supplements), By Distribution Channels (Hypermarkets & Supermarkets, E-Commerce, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing inclination toward following healthy and active lifestyle and growing importance of sports nutrition among athletes and sportspersons.

Endodontic Devices Market
https://www.delveinsight.com/report-store/endodontic-devices-market
Endodontic Devices Market By Product Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers, Handpieces, Machine-Assisted Obturation Systems, And Others], Consumables [Obturation, Access Cavity Preparation, Shaping And Cleaning]), By End-User (Dental Hospitals, Dental Clinics, And Others), and by geography is estimated to register growth at a remarkable CAGR during the forecast period from 2023-2028 owing to the rising patient pool associated with dental disorders, poor oral health, leading to increased number of root canal treatments, the increasing population opting for dental aesthetics, among others across the globe.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.